Market closed
Tevogen Bio Holdings Inc./$TVGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Ticker
$TVGN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
18
ISIN
US88165K1016
Website
TVGN Metrics
BasicAdvanced
$200M
-
-$0.07
-0.82
-
Price and volume
Market cap
$200M
Beta
-0.82
52-week high
$1.41
52-week low
$0.89
Average daily volume
1.2M
Financial strength
Current ratio
0.261
Quick ratio
0.159
Long term debt to equity
-15.07
Total debt to equity
-43.24
Interest coverage (TTM)
-291.05%
Management effectiveness
Return on assets (TTM)
-746.67%
Return on equity (TTM)
27.16%
Valuation
Price to book
-12.54
Price to tangible book (TTM)
-12.54
Price to free cash flow (TTM)
-13.324
Growth
Earnings per share change (TTM)
-97.13%
3-year earnings per share growth (CAGR)
-51.71%
TVGN News
AllArticlesVideos
Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
GlobeNewsWire·1 week ago
CD8 Technology Signs Letter of Intent for Tevogen Bio's In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
GlobeNewsWire·1 week ago
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Tevogen Bio Holdings Inc. stock?
Tevogen Bio Holdings Inc. (TVGN) has a market cap of $200M as of May 10, 2025.
What is the P/E ratio for Tevogen Bio Holdings Inc. stock?
The price to earnings (P/E) ratio for Tevogen Bio Holdings Inc. (TVGN) stock is 0 as of May 10, 2025.
Does Tevogen Bio Holdings Inc. stock pay dividends?
No, Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Tevogen Bio Holdings Inc. dividend payment date?
Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Tevogen Bio Holdings Inc.?
Tevogen Bio Holdings Inc. (TVGN) has a beta rating of -0.82. This means that it has an inverse relation to market volatility.